CH645019A5 - Loesungsmittelgemisch und verfahren zur herstellung von parenteral verabreichbaren injektionsloesungen. - Google Patents
Loesungsmittelgemisch und verfahren zur herstellung von parenteral verabreichbaren injektionsloesungen. Download PDFInfo
- Publication number
- CH645019A5 CH645019A5 CH813580A CH813580A CH645019A5 CH 645019 A5 CH645019 A5 CH 645019A5 CH 813580 A CH813580 A CH 813580A CH 813580 A CH813580 A CH 813580A CH 645019 A5 CH645019 A5 CH 645019A5
- Authority
- CH
- Switzerland
- Prior art keywords
- group
- general formula
- solvent mixture
- solution
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU79RI733A HU181940B (en) | 1979-11-02 | 1979-11-02 | Process for producing solutions of vincane derivatives for parentheral application |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH645019A5 true CH645019A5 (de) | 1984-09-14 |
Family
ID=11001115
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH813580A CH645019A5 (de) | 1979-11-02 | 1980-10-31 | Loesungsmittelgemisch und verfahren zur herstellung von parenteral verabreichbaren injektionsloesungen. |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US4344950A (OSRAM) |
| JP (1) | JPS56123911A (OSRAM) |
| AR (1) | AR223735A1 (OSRAM) |
| AT (1) | AT377914B (OSRAM) |
| AU (1) | AU533715B2 (OSRAM) |
| BE (1) | BE885987A (OSRAM) |
| CA (1) | CA1159367A (OSRAM) |
| CH (1) | CH645019A5 (OSRAM) |
| CS (1) | CS226417B2 (OSRAM) |
| DD (1) | DD153760A5 (OSRAM) |
| DE (1) | DE3041368A1 (OSRAM) |
| DK (1) | DK464680A (OSRAM) |
| FI (1) | FI803401L (OSRAM) |
| FR (1) | FR2468373A1 (OSRAM) |
| GB (1) | GB2062464B (OSRAM) |
| HU (1) | HU181940B (OSRAM) |
| IL (1) | IL61310A (OSRAM) |
| IT (1) | IT1209367B (OSRAM) |
| NL (1) | NL8005980A (OSRAM) |
| NO (1) | NO803254L (OSRAM) |
| PH (1) | PH17037A (OSRAM) |
| SE (1) | SE8007569L (OSRAM) |
| YU (1) | YU278880A (OSRAM) |
| ZA (1) | ZA806468B (OSRAM) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1170152B (it) * | 1982-07-19 | 1987-06-03 | Lilly Co Eli | Miglioramenti a o riguardanti formulazioni di vinca-alcaloidi |
| US4619935A (en) * | 1983-03-17 | 1986-10-28 | Eli Lilly And Company | Stable oncolytic formulations |
| US5360593A (en) * | 1987-12-29 | 1994-11-01 | Alcon Laboratories, Inc. | Heat sterilization of labile antibiotics |
| CN101721361B (zh) * | 2009-12-08 | 2013-06-26 | 李荣立 | 长春胺注射剂及其制备工艺 |
| CN112649522B (zh) * | 2020-11-30 | 2022-02-22 | 海南葫芦娃药业集团股份有限公司 | 一种注射液中有关物质长春胺酸与阿朴长春胺酸的检测方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3005754A (en) * | 1957-08-16 | 1961-10-24 | Bristol Myers Co | Tetracycline formulations |
| US3155586A (en) * | 1963-01-23 | 1964-11-03 | American Cyanamid Co | Stable liquid preparations of 6-demethyltetracyclines |
| US3159542A (en) * | 1962-12-31 | 1964-12-01 | American Cyanamid Co | Stable aqueous glycol solution of tetracycline aluminum calcium gluconate complex having a ph of about 7. 5 to 9 |
| GB1005342A (en) * | 1963-01-23 | 1965-09-22 | Olin Mathieson | Pharmaceutical preparations containing choline ester salts |
| FR2191891B1 (OSRAM) * | 1972-07-13 | 1975-08-08 | Roussel Uclaf | |
| FR2279394A2 (fr) * | 1973-12-13 | 1976-02-20 | Saunier Laboratoires | Medicament pour le traitement des insuffisances circulatoires cerebrales |
-
1979
- 1979-11-02 HU HU79RI733A patent/HU181940B/hu unknown
-
1980
- 1980-10-20 IL IL61310A patent/IL61310A/xx unknown
- 1980-10-21 ZA ZA00806468A patent/ZA806468B/xx unknown
- 1980-10-23 CS CS807199A patent/CS226417B2/cs unknown
- 1980-10-27 AT AT0527980A patent/AT377914B/de not_active IP Right Cessation
- 1980-10-28 SE SE8007569A patent/SE8007569L/ unknown
- 1980-10-28 US US06/201,509 patent/US4344950A/en not_active Expired - Lifetime
- 1980-10-30 YU YU02788/80A patent/YU278880A/xx unknown
- 1980-10-30 FI FI803401A patent/FI803401L/fi not_active Application Discontinuation
- 1980-10-31 CA CA000363725A patent/CA1159367A/en not_active Expired
- 1980-10-31 JP JP15235880A patent/JPS56123911A/ja active Pending
- 1980-10-31 FR FR8023347A patent/FR2468373A1/fr active Granted
- 1980-10-31 NO NO803254A patent/NO803254L/no unknown
- 1980-10-31 BE BE0/202670A patent/BE885987A/fr not_active IP Right Cessation
- 1980-10-31 CH CH813580A patent/CH645019A5/de not_active IP Right Cessation
- 1980-10-31 AU AU64004/80A patent/AU533715B2/en not_active Ceased
- 1980-10-31 IT IT8025683A patent/IT1209367B/it active
- 1980-10-31 NL NL8005980A patent/NL8005980A/nl not_active Application Discontinuation
- 1980-10-31 AR AR283093A patent/AR223735A1/es active
- 1980-10-31 DD DD80224849A patent/DD153760A5/de unknown
- 1980-10-31 GB GB8035112A patent/GB2062464B/en not_active Expired
- 1980-10-31 DK DK464680A patent/DK464680A/da not_active Application Discontinuation
- 1980-11-02 PH PH24934A patent/PH17037A/en unknown
- 1980-11-03 DE DE19803041368 patent/DE3041368A1/de not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CS226417B2 (en) | 1984-03-19 |
| IL61310A0 (en) | 1980-12-31 |
| GB2062464A (en) | 1981-05-28 |
| FR2468373A1 (fr) | 1981-05-08 |
| DK464680A (da) | 1981-05-03 |
| ZA806468B (en) | 1981-10-28 |
| BE885987A (fr) | 1981-02-16 |
| FI803401A7 (fi) | 1981-05-03 |
| IT8025683A0 (it) | 1980-10-31 |
| SE8007569L (sv) | 1981-05-03 |
| HU181940B (en) | 1983-11-28 |
| JPS56123911A (en) | 1981-09-29 |
| IL61310A (en) | 1984-08-31 |
| DD153760A5 (de) | 1982-02-03 |
| FI803401L (fi) | 1981-05-03 |
| PH17037A (en) | 1984-05-17 |
| US4344950A (en) | 1982-08-17 |
| YU278880A (en) | 1984-04-30 |
| AR223735A1 (es) | 1981-09-15 |
| FR2468373B1 (OSRAM) | 1984-12-28 |
| AT377914B (de) | 1985-05-28 |
| GB2062464B (en) | 1983-12-07 |
| CA1159367A (en) | 1983-12-27 |
| NL8005980A (nl) | 1981-06-01 |
| NO803254L (no) | 1981-05-04 |
| ATA527980A (de) | 1984-10-15 |
| DE3041368A1 (de) | 1981-05-14 |
| AU6400480A (en) | 1981-05-07 |
| IT1209367B (it) | 1989-07-16 |
| AU533715B2 (en) | 1983-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69223624T2 (de) | Taxan-derivate enthaltende arzneimittel | |
| EP0049852B1 (de) | Pharmazeutisches Präparat und seine Herstellung | |
| DE2343657A1 (de) | Neuer ester eines eckige klammer auf (methylamino)methyl eckige klammer zu benzyl-alkohols | |
| DE2620483A1 (de) | Stabile waessrige insulinloesungen | |
| DE3042332A1 (de) | Waessrige nitroglycerinloesung | |
| EP0806955B1 (de) | Enrofloxacin-injektions- oder infusionslösungen | |
| CH645019A5 (de) | Loesungsmittelgemisch und verfahren zur herstellung von parenteral verabreichbaren injektionsloesungen. | |
| DE69023939T2 (de) | Förderung der Osteogenese durch Verwendung von Vitamin D-Derivaten. | |
| DE60101979T2 (de) | Lösung enthaltend N-[O-(p-pivaloyloxybenzenesulfonylamino)benzoyl]glyzin Mononatriumsalz Tetrahydrat und diese Lösung enthaltendes Arzneimittel | |
| DE69922252T2 (de) | Parenterale lösungen enthaltend propofol (2,6-diisopropylphenol) und 2.5-di-0-methyl-1.4;3.6-dianhydro-d-glucitol als lösungsmittel | |
| DE3011274A1 (de) | Synergistische strahlenschuetzende pharmazeutische praeparate sowie deren herstellung | |
| DE1231847B (de) | Verfahren zur Herstellung von parenteral applizierbaren waessrigen Loesungen von substituierten Benzochinonen | |
| DE2036935A1 (de) | Verfahren zur Herstellung von Isoniazid derivaten | |
| DE2500599C2 (de) | Vincamin-2-ketoglutarat, Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel | |
| DE2110436C3 (de) | Verfahren zur Herstellung eines antileukopenischen und antikörperbildenden Thymusextrakts aus Kalbsthymus | |
| DE1792448C3 (de) | Verfahren zur Herstellung von zur parenteralen Verabreichung geeigneten stabilen Lösungen von therapeutisch anwendbaren Benzodiazepinderivaten | |
| DE2835987A1 (de) | 3-amino-17a-aza-d-homo-5 alpha -androstanderivate und quaternaere salze davon sowie verfahren zu ihrer herstellung | |
| DE3044736A1 (de) | Antitumor-mittel, verfahren zu deren herstellung und dosierungsformen | |
| DE3701461C2 (OSRAM) | ||
| DE3102026C2 (OSRAM) | ||
| DE1467743A1 (de) | Verfahren zur Herstellung eines Praeparats mit verlaengerter Vitamin B 12-Wirkung | |
| CH656533A5 (de) | Therapeutisches praeparat enthaltend hydrierte ergotalkaloide und niedermolekulares heparin. | |
| DE1179336B (de) | Roentgenkontrastmittel | |
| DE2152001C3 (de) | 3-Piperidino- und 3-Morpholinopropylbenzoate und deren Salze, Verfahren zur Herstellung derselben sowie solche Verbindungen enthaltende Arzneimittel | |
| DE1595951A1 (de) | Verfahren zur Herstellung von Desoxyuridinverbindungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased | ||
| PL | Patent ceased |